Variant report
Variant | esv3330985 |
---|---|
Chromosome Location | chr3:133279413-133279793 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:133279685..133281617-chr3:133285489..133287947,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs66549971 | chr3:133279435-133279436 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs188806659 | chr3:133279451-133279452 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs575918408 | chr3:133279523-133279524 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs544535470 | chr3:133279539-133279540 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs563296076 | chr3:133279553-133279554 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs138380593 | chr3:133279594-133279595 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs148509038 | chr3:133279595-133279596 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs150992330 | chr3:133279600-133279601 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs376830828 | chr3:133279602-133279603 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs140239430 | chr3:133279603-133279604 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs369362415 | chr3:133279606-133279607 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs111996381 | chr3:133279612-133279613 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs568226759 | chr3:133279620-133279621 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs548508199 | chr3:133279664-133279665 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs550555341 | chr3:133279692-133279693 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs562011021 | chr3:133279723-133279724 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs538205595 | chr3:133279741-133279742 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs62280438 | chr3:133279742-133279743 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs539490763 | chr3:133279743-133279744 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs552935337 | chr3:133279745-133279746 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs573031581 | chr3:133279746-133279747 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs138638579 | chr3:133279754-133279755 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs181615571 | chr3:133279762-133279763 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs141220933 | chr3:133279763-133279764 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs544785872 | chr3:133279766-133279767 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs532660616 | chr3:133279779-133279780 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs377411426 | chr3:133279783-133279784 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs115384670 | chr3:133279788-133279789 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs150316794 | chr3:133279792-133279793 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 18645599 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Hailey-hailey disease | 17597066 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Lung cancer | 16740712 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Blepharophimosis-ptosis-epicanthus inversus syndrome | 22067867 | CNVD |
Cancer | 20164919 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:133270600-133281200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr3:133279200-133281800 | Enhancers | Placenta | Placenta |